3LIBBY P, RIDIKER P M, MASERI A. Inflammation and atherosclerosis[J]. Circulation, 2002,105:1135-1143. 被引量：1
4LANGMAN L J, RAY J G, EVROVSKI J. Hyperhomocyst (e) inemia and the increased risk of venous thromboembolism:more evidence form a case-control study[J].Arch Intern Med,2000,160:961-964. 被引量：1
5TANIGCHI A, NAGASAKA S, FUKUSHIMA M, et al.Creaction protein and insulin resistance in non-obese Japanese type 2 diabetic patient [J]. Metabolism, 2002,51: 1578-1581. 被引量：1
6Langman LJ,Ray JG,Evrovski J.Hyperhomocyst(e) inemia and the increased risk of venous thromboembolism:more evidence form a case-control study[J].Arch Intern Med,2000,160:961-964. 被引量：1
7Quere I,Perneger TV,Zittoun J,et al.Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboebolism:a matched case-control study[J].Lancet,2002,359:747-752 被引量：1
8Ewart H K M,Rider P M,Rifai N,et al. Absence of diurnal variation of C-reactive protein levels in healthy human subjects [J]. Clin Chem,2001,47:426-430. 被引量：1
9Taniguchi A, Nagasaka S, Fukushima M, et al. C-reaction protein and insulin resistance in non-obese Japanese type 2 diabetic patient [J].Metabolism,2002,51:1578-1581. 被引量：1
10Kabrhel C, Mark Courtney D, Camargo CA Jr, et al. Factors associated with positive D - dimer results in patients evaluated for pulmonary embolism[J]. Aead Emerg Med, 2010, 17(6) : 589 - 597. 被引量：1
